Streamline Health Solutions Inc (STRM)
0.316
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.331
+0.02
(+4.75%)
After-Hours: 20:00
Streamline Health Solutions Research and Development Expense (Quarterly): 1.394M for Jan. 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 1.394M |
| October 31, 2023 | 1.304M |
| July 31, 2023 | 1.305M |
| April 30, 2023 | 1.701M |
| January 31, 2023 | 1.515M |
| October 31, 2022 | 1.754M |
| July 31, 2022 | 1.461M |
| April 30, 2022 | 1.312M |
| January 31, 2022 | 1.502M |
| October 31, 2021 | 1.339M |
| July 31, 2021 | 0.964M |
| April 30, 2021 | 0.977M |
| January 31, 2021 | 0.987M |
| October 31, 2020 | 0.753M |
| July 31, 2020 | 0.509M |
| April 30, 2020 | 0.684M |
| January 31, 2020 | 0.94M |
| October 31, 2019 | 0.501M |
| July 31, 2019 | 0.66M |
| April 30, 2019 | 0.589M |
| January 31, 2019 | 0.959M |
| October 31, 2018 | 1.026M |
| July 31, 2018 | 1.213M |
| April 30, 2018 | 1.062M |
| January 31, 2018 | 1.367M |
| Date | Value |
|---|---|
| October 31, 2017 | 0.9323M |
| July 31, 2017 | 1.496M |
| April 30, 2017 | 1.557M |
| January 31, 2017 | 1.654M |
| October 31, 2016 | 1.969M |
| July 31, 2016 | 2.109M |
| April 30, 2016 | 1.722M |
| January 31, 2016 | 2.378M |
| October 31, 2015 | 2.258M |
| July 31, 2015 | 2.233M |
| April 30, 2015 | 2.224M |
| January 31, 2015 | 2.905M |
| October 31, 2014 | 2.275M |
| July 31, 2014 | 2.225M |
| April 30, 2014 | 2.350M |
| January 31, 2014 | 3.461M |
| October 31, 2013 | 1.370M |
| July 31, 2013 | 1.160M |
| April 30, 2013 | 1.097M |
| January 31, 2013 | 1.114M |
| October 31, 2012 | 0.8667M |
| July 31, 2012 | 0.5108M |
| April 30, 2012 | 0.4564M |
| January 31, 2012 | 0.3448M |
| October 31, 2011 | 0.304M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.501M
Minimum
Oct 2019
1.754M
Maximum
Oct 2022
1.135M
Average
1.304M
Median
Oct 2023
Research and Development Expense (Quarterly) Benchmarks
| TruBridge Inc | 10.69M |
| Veradigm Inc | 23.68M |
| LifeMD Inc | 2.087M |
| PetMed Express Inc | -- |
| LENZ Therapeutics Inc | 10.54M |